Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001641172-25-007948
Filing Date
2025-05-01
Accepted
2025-04-30 20:10:19
Documents
76

Document Format Files

Seq Description Document Type Size
1 S-1/A forms-1a.htm   iXBRL S-1/A 1677089
2 EX-5.1 ex5-1.htm EX-5.1 14602
3 EX-23.1 ex23-1.htm EX-23.1 4536
4 EX-FILING FEES ex107.htm EX-FILING FEES 34465
5 GRAPHIC ex5-1_001.jpg GRAPHIC 3441
  Complete submission text file 0001641172-25-007948.txt   8036300

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE awh-20241231.xsd EX-101.SCH 63271
7 XBRL CALCULATION FILE awh-20241231_cal.xml EX-101.CAL 62153
8 XBRL DEFINITION FILE awh-20241231_def.xml EX-101.DEF 302470
9 XBRL LABEL FILE awh-20241231_lab.xml EX-101.LAB 504201
10 XBRL PRESENTATION FILE awh-20241231_pre.xml EX-101.PRE 377999
79 EXTRACTED XBRL INSTANCE DOCUMENT forms-1a_htm.xml XML 1056386
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

EIN.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-286561 | Film No.: 25898763
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)